Medicine
Besivance 6 mg/mL ophthalmic suspension
Besivance 6 mg/mL ophthalmic suspension is a prescription medicine containing Besifloxacin for ophthalmic use, marketed by Bausch & Lomb, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15°C to 25°C (59°F to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Besifloxacin
- Brand
- Besivance
- Strength
- 6 mg/mL
- Dosage form
- Ophthalmic suspension
- Route
- Ophthalmic
- Packs
- 1 bottle and 2 more
- Marketing authorisation holder
- Bausch & Lomb
- Manufacturers
- Bausch & LombSportpharmBausch & Lomb Americas
- Origin register
- US FDA, United States
- Storage
- Store at 15°C to 25°C (59°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01AE08 Besifloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 May 2009
- Identifiers
- RxCUI 850305, 850309DailyMed set ID ff971287-5610-4f15-8392-fc974e6ff646, a3e6d688-7e5e-4ca3-b27e-79756c322a32, f312ddb2-3173-4c2c-bf1b-4ade8fb75d94 +1NDC 82260-466, 24208-446, 85766-260 +1Application NDA022308
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, dropper in 1 carton / 2 mL in 1 bottle, dropper | 24208-446-02 | Bausch & Lomb | 28 May 2009 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 24208-446-05 | Bausch & Lomb | 28 May 2009 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 82260-466-05 | Bausch & Lomb Americas | 9 January 2026 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 85766-257-05 | Sportpharm | 23 July 2026 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 85766-260-05 | Sportpharm | 28 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 May 2009 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Besifloxacin is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of bacteria. It is available as ophthalmic suspension. MedsAcross supplies Besifloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BesifloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Besivance prescribing information (Bausch & Lomb Americas) · U.S. National Library of Medicine, DailyMed
Need Besivance 6 mg/mL ophthalmic suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.